Gabriela Ortiz-omphroy Md Llc - Medicare Primary Care in Aiea, HI

Gabriela Ortiz-omphroy Md Llc is a medicare enrolled primary clinic (Family Medicine) in Aiea, Hawaii. The current practice location for Gabriela Ortiz-omphroy Md Llc is 98-1079 Moanalua Rd Ste 680, Aiea, Hawaii. For appointments, you can reach them via phone at (808) 488-4342. The mailing address for Gabriela Ortiz-omphroy Md Llc is 98-1079 Moanalua Rd Ste 680, Aiea, Hawaii and phone number is (808) 488-4342.

Gabriela Ortiz-omphroy Md Llc is licensed to practice in Hawaii (license number 12351). The clinic also participates in the medicare program and its NPI number is 1285994525. This medical practice accepts medicare insurance (which means this clinic accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance). However, please confirm if they accept your insurance at (808) 488-4342.

Contact Information

Gabriela Ortiz-omphroy Md Llc
98-1079 Moanalua Rd Ste 680
Aiea
HI 96701-4725
(808) 488-4342
(808) 488-4151

Primary Care Clinic Profile

Full NameGabriela Ortiz-omphroy Md Llc
SpecialityFamily Medicine
Location98-1079 Moanalua Rd Ste 680, Aiea, Hawaii
Authorized Official Name and PositionGabriela M Ortiz-omphroy (OWNER)
Authorized Official Contact8084884342
Accepts Medicare InsuranceYes. This clinic participates in medicare program and accept medicare insurance.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Gabriela Ortiz-omphroy Md Llc
98-1079 Moanalua Rd Ste 680
Aiea
HI 96701-4725

Ph: (808) 488-4342
Gabriela Ortiz-omphroy Md Llc
98-1079 Moanalua Rd Ste 680
Aiea
HI 96701-4725

Ph: (808) 488-4342

NPI Details:

NPI Number1285994525
Provider Enumeration Date05/21/2012
Last Update Date08/30/2012

Medicare PECOS Information:

Medicare PECOS PAC ID5991952012
Medicare Enrollment IDO20120824000472

News Archive

Blood biopsy helps identify targetable genetic alterations in patients with cancer of unknown primary

Using fragments of circulating tumor DNA in blood, University of California San Diego School of Medicine researchers were able to identify theoretically targetable genetic alterations in 66 percent of patients with cancer of unknown primary (CUP), a rare disease with seven to 12 cases per 100,000 people each year.

One dose of Pfizer vaccine generates strong immune response against COVID-19

​A new study led by the Universities of Sheffield and Oxford with support from the UK Coronavirus Immunology Consortium (UK-CIC) has found that 99 per cent of people generate a robust immune response against Covid-19 after just one dose of the Pfizer vaccine.

Growth of lymph node metastases takes advantage of existing blood vessels

While the use of antiangiogenesis drugs that block the growth of new blood vessels can improve the treatment of some cancers, clinical trials of their ability to prevent the development of new metastases have failed. Now a study from the Massachusetts General Hospital Cancer Center may have found at least one reason why.

First epoetin alfa biosimilar receives FDA approval to treat certain types of anemia

The U.S. Food and Drug Administration today approved Retacrit (epoetin alfa-epbx) as a biosimilar to Epogen/Procrit (epoetin alfa) for the treatment of anemia caused by chronic kidney disease, chemotherapy, or use of zidovudine in patients with HIV infection.

New supercomputer rating system to be released

A new supercomputer rating system will be released by an international team led by Sandia National Laboratories at the Supercomputing Conference 2010 in New Orleans on Nov. 17.

Read more Medical News

› Verified 1 days ago

Medical Identifiers

Medical identifiers for Gabriela Ortiz-omphroy Md Llc such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1285994525NPI-NPPES
53927313MedicaidHI

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207Q00000XFamily Medicine 12351 (Hawaii)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Gabriela Ortiz-omphroy Md Llc acts as a billing entity for following providers:
Provider NameCatherine J Tsang
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1154525368
PECOS PAC ID: 5395891725
Enrollment ID: I20090925000396

News Archive

Blood biopsy helps identify targetable genetic alterations in patients with cancer of unknown primary

Using fragments of circulating tumor DNA in blood, University of California San Diego School of Medicine researchers were able to identify theoretically targetable genetic alterations in 66 percent of patients with cancer of unknown primary (CUP), a rare disease with seven to 12 cases per 100,000 people each year.

One dose of Pfizer vaccine generates strong immune response against COVID-19

​A new study led by the Universities of Sheffield and Oxford with support from the UK Coronavirus Immunology Consortium (UK-CIC) has found that 99 per cent of people generate a robust immune response against Covid-19 after just one dose of the Pfizer vaccine.

Growth of lymph node metastases takes advantage of existing blood vessels

While the use of antiangiogenesis drugs that block the growth of new blood vessels can improve the treatment of some cancers, clinical trials of their ability to prevent the development of new metastases have failed. Now a study from the Massachusetts General Hospital Cancer Center may have found at least one reason why.

First epoetin alfa biosimilar receives FDA approval to treat certain types of anemia

The U.S. Food and Drug Administration today approved Retacrit (epoetin alfa-epbx) as a biosimilar to Epogen/Procrit (epoetin alfa) for the treatment of anemia caused by chronic kidney disease, chemotherapy, or use of zidovudine in patients with HIV infection.

New supercomputer rating system to be released

A new supercomputer rating system will be released by an international team led by Sandia National Laboratories at the Supercomputing Conference 2010 in New Orleans on Nov. 17.

Read more Medical News

› Verified 1 days ago

Provider NameGabriela M Ortiz Omphroy
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1093879884
PECOS PAC ID: 6002708153
Enrollment ID: I20100924000147

News Archive

Blood biopsy helps identify targetable genetic alterations in patients with cancer of unknown primary

Using fragments of circulating tumor DNA in blood, University of California San Diego School of Medicine researchers were able to identify theoretically targetable genetic alterations in 66 percent of patients with cancer of unknown primary (CUP), a rare disease with seven to 12 cases per 100,000 people each year.

One dose of Pfizer vaccine generates strong immune response against COVID-19

​A new study led by the Universities of Sheffield and Oxford with support from the UK Coronavirus Immunology Consortium (UK-CIC) has found that 99 per cent of people generate a robust immune response against Covid-19 after just one dose of the Pfizer vaccine.

Growth of lymph node metastases takes advantage of existing blood vessels

While the use of antiangiogenesis drugs that block the growth of new blood vessels can improve the treatment of some cancers, clinical trials of their ability to prevent the development of new metastases have failed. Now a study from the Massachusetts General Hospital Cancer Center may have found at least one reason why.

First epoetin alfa biosimilar receives FDA approval to treat certain types of anemia

The U.S. Food and Drug Administration today approved Retacrit (epoetin alfa-epbx) as a biosimilar to Epogen/Procrit (epoetin alfa) for the treatment of anemia caused by chronic kidney disease, chemotherapy, or use of zidovudine in patients with HIV infection.

New supercomputer rating system to be released

A new supercomputer rating system will be released by an international team led by Sandia National Laboratories at the Supercomputing Conference 2010 in New Orleans on Nov. 17.

Read more Medical News

› Verified 1 days ago

Provider NameMelyssa Majano
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1871039891
PECOS PAC ID: 0345514790
Enrollment ID: I20170922002292

News Archive

Blood biopsy helps identify targetable genetic alterations in patients with cancer of unknown primary

Using fragments of circulating tumor DNA in blood, University of California San Diego School of Medicine researchers were able to identify theoretically targetable genetic alterations in 66 percent of patients with cancer of unknown primary (CUP), a rare disease with seven to 12 cases per 100,000 people each year.

One dose of Pfizer vaccine generates strong immune response against COVID-19

​A new study led by the Universities of Sheffield and Oxford with support from the UK Coronavirus Immunology Consortium (UK-CIC) has found that 99 per cent of people generate a robust immune response against Covid-19 after just one dose of the Pfizer vaccine.

Growth of lymph node metastases takes advantage of existing blood vessels

While the use of antiangiogenesis drugs that block the growth of new blood vessels can improve the treatment of some cancers, clinical trials of their ability to prevent the development of new metastases have failed. Now a study from the Massachusetts General Hospital Cancer Center may have found at least one reason why.

First epoetin alfa biosimilar receives FDA approval to treat certain types of anemia

The U.S. Food and Drug Administration today approved Retacrit (epoetin alfa-epbx) as a biosimilar to Epogen/Procrit (epoetin alfa) for the treatment of anemia caused by chronic kidney disease, chemotherapy, or use of zidovudine in patients with HIV infection.

New supercomputer rating system to be released

A new supercomputer rating system will be released by an international team led by Sandia National Laboratories at the Supercomputing Conference 2010 in New Orleans on Nov. 17.

Read more Medical News

› Verified 1 days ago

News Archive

Blood biopsy helps identify targetable genetic alterations in patients with cancer of unknown primary

Using fragments of circulating tumor DNA in blood, University of California San Diego School of Medicine researchers were able to identify theoretically targetable genetic alterations in 66 percent of patients with cancer of unknown primary (CUP), a rare disease with seven to 12 cases per 100,000 people each year.

One dose of Pfizer vaccine generates strong immune response against COVID-19

​A new study led by the Universities of Sheffield and Oxford with support from the UK Coronavirus Immunology Consortium (UK-CIC) has found that 99 per cent of people generate a robust immune response against Covid-19 after just one dose of the Pfizer vaccine.

Growth of lymph node metastases takes advantage of existing blood vessels

While the use of antiangiogenesis drugs that block the growth of new blood vessels can improve the treatment of some cancers, clinical trials of their ability to prevent the development of new metastases have failed. Now a study from the Massachusetts General Hospital Cancer Center may have found at least one reason why.

First epoetin alfa biosimilar receives FDA approval to treat certain types of anemia

The U.S. Food and Drug Administration today approved Retacrit (epoetin alfa-epbx) as a biosimilar to Epogen/Procrit (epoetin alfa) for the treatment of anemia caused by chronic kidney disease, chemotherapy, or use of zidovudine in patients with HIV infection.

New supercomputer rating system to be released

A new supercomputer rating system will be released by an international team led by Sandia National Laboratories at the Supercomputing Conference 2010 in New Orleans on Nov. 17.

Read more News

› Verified 1 days ago


Family Medicine in Aiea, HI

Rice Consultancy Llc
Primary Care Clinic
Medicare: Medicare Enrolled
Practice Location: 98-211 Pali Momi St, Suite 312, Aiea, HI 96701
Phone: 808-486-0449    Fax: 808-488-0725
Ky Le Llc
Primary Care Clinic
Medicare: Medicare Enrolled
Practice Location: 98-1079 Moanalua Rd, Aiea, HI 96701
Phone: 808-536-0300    
Yousif A-rahim Md Inc
Primary Care Clinic
Medicare: Medicare Enrolled
Practice Location: 98-211 Pali Momi St, 312, Aiea, HI 96701
Phone: 808-486-0449    Fax: 808-488-0725
Luis J. Ragunton, M.d., Inc.
Primary Care Clinic
Medicare: Medicare Enrolled
Practice Location: 98-1079 Moanalua Rd, Suite 440, Aiea, HI 96701
Phone: 808-488-8750    Fax: 808-487-5910
Mark A Morisaki Md Inc
Primary Care Clinic
Medicare: Medicare Enrolled
Practice Location: 98-1079 Moanalua Rd Ste 620, Aiea, HI 96701
Phone: 808-488-2224    
Randall J. Nitta, Md, Llc
Primary Care Clinic
Medicare: Medicare Enrolled
Practice Location: 98-1247 Kaahumanu St Ste 306, Aiea, HI 96701
Phone: 808-484-2904    Fax: 808-484-2864
Robert Wong, Md, L.l.c.
Primary Care Clinic
Medicare: Medicare Enrolled
Practice Location: 98-211 Pali Momi Street, Suite 312, Aiea, HI 96701
Phone: 808-486-0449    Fax: 808-488-0725

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.